What Changed in the CY 2027 Physician Fee Schedule for MSSP ACOs
On November 9, 2026, CMS finalized the CY 2027 Physician Fee Schedule (CMS-1848-F). For the typical ACO leader, the headline is a 2.8% conversion factor cut. But the real operational story sits in four MSSP-specific provisions that will reshape how benchmarks are set, how growth is rewarded, and how cost-sharing waivers work starting April 1, 2027.
This post walks through each change, what it means for your shared savings math, and the data infrastructure moves you should be making before January 1.
The Four MSSP Changes That Actually Matter
1. The ACO Growth Adjustment: 5% of Benchmark × New Growth Share
CMS is adding a new ACO growth adjustment equal to 5% of the ACO's unadjusted historical benchmark, multiplied by the ACO's share of beneficiaries and clinicians new to value-based care. This is not a footnote — for a mid-sized ACO with 25,000 attributed lives and a $1,200 average benchmark, that could translate to $1.5M in upside for an ACO bringing in 10% new-to-VBC participants.
The catch: "new to value-based care" is defined narrowly. Beneficiaries previously attributed to any MSSP, ACO REACH, LEAD, or Kidney Care Choices ACO won't qualify. That means your team needs clean attribution data going back at least three years — something most ACOs are only partially ready for today.
2. Prior Savings Adjustment Scaling Factor: 50% → 75%
The prior savings adjustment has been a persistent frustration for high performers: the better you do, the more your benchmark gets ratcheted down. CMS is raising the scaling factor from 50% to 75%, which sounds like a tightening but actually improves the accuracy of the adjustment. The effect is a slightly higher benchmark for ACOs with modest prior savings and a more precisely discounted benchmark for strong performers. Net result: less benchmark compression for the median ACO.
This change is directionally positive but requires your finance team to rerun 2027 benchmark projections with the updated parameter before the December 31 performance year close.
3. ACO Payment Modifier Replaces G2211
The flat G2211 complexity add-on for primary care complexity is being replaced by an ACO-specific payment modifier. The new modifier pays differently depending on ACO performance tier — meaning clinicians in a high-performing ACO will see a higher add-on than those in a first-year track. CMS hasn't finalized the exact tier-to-dollar mapping yet, but the structure creates a direct financial incentive at the clinician level to close care gaps that move ACO performance scores.
Practically, your practice management system will need to track the modifier and feed attribution-adjusted claims back to the ACO's reconciliation model. For health system-based ACOs, this means aligning revenue cycle and population health workflows that often live in completely separate systems.
4. Part B Cost-Sharing Waivers Start April 1, 2027
Starting April 1, 2027, CMS-approved ACOs may waive Part B cost sharing for attributed beneficiaries. This is significant for care gap closure: historically, the copay at a specialist or at an AWV visit was a real barrier for dual-eligible and low-income Medicare patients. Waiving it removes the last financial friction point between your outreach call and a completed encounter.
For dual-eligible beneficiaries — where Medicaid covers cost sharing anyway — the waiver matters less. But for the slice of your panel that's Medicare-only and near poverty, this could meaningfully improve AWV completion rates in Q2 2027. Eternal Health's experience with dual-eligible members showed that proactive cost barrier removal drove 23% higher engagement rates in its first year.
What NAACOS and MGMA Got Wrong in Their Reactions
NAACOS praised the benchmark changes. MGMA called the conversion factor cuts destabilizing. Both are right — and both miss the point for ACO leaders specifically.
The conversion factor cut (-2.8%) affects everyone. ACOs don't absorb it in a vacuum; your attributed clinicians do, and reduced clinician revenue creates real pressure to exit value-based arrangements. If you don't have clear per-clinician savings attribution data showing each physician their direct share of shared savings, the conversion factor cut is an unmitigated negative that undercuts your ACO's ability to retain participating physicians.
The benchmark changes, by contrast, are ACO-specific upside. The right read is: the 2027 PFS makes staying in MSSP more attractive for growth-stage ACOs while making the clinician retention math harder. Those are solvable in opposite directions but require real-time data, not quarterly reports.
Customer Results That Inform This Analysis
Zynix has worked with PBACO, a physician-based ACO that struggled with AWV gap closure heading into its 2026 performance year. By deploying AI-driven outreach and care gap prioritization, PBACO moved from 61% AWV completion to 84% in a single performance year — a delta that, under the new cost-sharing waiver starting April 2027, would be even easier to replicate. The lesson: the structural reforms CMS is making only pay off if you have the outreach infrastructure to act on them at scale.
Union Health's HEDIS performance work offers a parallel lesson. When Union Health deployed Zynix's care gap engine, it identified 2,100 patients with open quality measure gaps that manual review had missed. Under the new ACO payment modifier structure — where ACO performance tier directly determines clinician payment — that kind of gap closure moves money in ways the flat G2211 never did.
The Data Infrastructure Moves to Make Before January 1
Three things your team should be doing now, not in March:
- Run your 2027 benchmark projection with the 75% prior savings scaling factor. Most ACO finance tools haven't been updated yet. If yours hasn't, model it manually. The difference between the 50% and 75% factor can swing your projected benchmark by $400–$900 per beneficiary for high-performing ACOs.
- Identify your "new to VBC" beneficiary and clinician pool now. The 5% growth adjustment requires clean attribution history. Start the data pull now so you're not scrambling in Q1 when CMS attribution data lags become an issue.
- Map your dual-eligible and cost-sharing-sensitive panel segments. The April 1 cost-sharing waiver is only valuable if you can target outreach to beneficiaries for whom cost sharing was an actual barrier. If you don't have that segmentation built, it's a 6-week project — not a 2-week project.
For ACOs running care management workflows that span multiple EHRs, the gap between "we have the data" and "we can act on it in time" is exactly where Zynix's platform lives. HCN, which scaled care management across a multi-site network, was able to standardize that attribution and gap-closure workflow across 14 practice locations — the same operational discipline the 2027 PFS is now financially rewarding.
If you want a sharper look at the operational mechanics of ACO benchmarking and attribution history, the post on how MSSP, ACO REACH, and LEAD work in 2026 and 2027 gives useful context. And if you're heading into Q4 with open quality gaps, the HEDIS MY2026 year-end sprint guide covers the gap-closure mechanics that determine your ACO performance tier — which now directly maps to the ACO payment modifier your clinicians will receive.
If you're running an ACO, MSO, or value-based contract and you're heading into a 2027 benchmark reset with less than 12% shared savings performance against your 2026 target — let's talk.
Gautam Chowdhary (CTO & Co-founder) personally takes a handful of 15-minute intro calls each week. No slide deck — just your 3 hardest VBC operational problems and whether Zynix can close the gap in <60 days.
Book at: zynix.ai/cclf-opportunity-analysis